Back

Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: a Danish nationwide cohort study

Mkoma, G.; Agyemang, C.; Benfield, T. L.; Rostila, M.; Cederström, A.; Petersen, J. H.; Norredam, M.

2023-08-24 public and global health
10.1101/2023.08.22.23294402 medRxiv
Show abstract

BackgroundEthnic minorities living in high-income countries have been disproportionately affected by COVID-19 in terms of infection rates and hospitalisations; however, less is known about long COVID in this population. Our aim was to examine the risk of long COVID and associated symptoms among ethnic minorities. Methods and FindingsA Danish nationwide register-based cohort study of individuals diagnosed with COVID-19 aged [≥]18 years (n=2 334 271) between January 2020 and August 2022. We calculated the risk of long COVID diagnosis and long COVID symptoms among ethnic minorities compared with native Danes using multivariable Cox proportional hazard regression and logistic regression, respectively. Ethnic minorities from North Africa (adjusted hazard ratio [aHR] 1.41; 95% CI 1.12-1.79), Middle East (aHR 1.38; 95% CI 1.24-1.55), Eastern Europe (aHR 1.35; 95% CI 1.22-1.49), and Asia (aHR 1.23; 95% CI 1.09-1.40) had significantly greater risk of long COVID diagnosis than native Danes in both unadjusted and adjusted models. In the analysis by largest countries of origin, the greater risks of long COVID diagnosis were found in Iraqis (aHR 1.56; 95% CI 1.30- 1.88), Turks (aHR 1.42; 95% CI 1.24-1.63), and Somalis (aHR 1.42; 95% CI 1.07-1.91) after adjustment for confounders. Significant factor associated with an increased risk of long COVID diagnosis was COVID-19 hospitalisation. Furthermore, the odds of reporting cardiopulmonary symptoms (including dyspnoea, cough, and chest pain) and any long COVID symptoms were higher among North African, Middle Eastern, Eastern European, and Asian than among native Danes in both unadjusted and adjusted models. ConclusionsBelonging to an ethnic minority group was significantly associated with an increased risk of long COVID indicating the need to better understand long COVID drivers and address care and treatment strategies in this population.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 7%
22.4%
2
BMJ Open
554 papers in training set
Top 2%
8.4%
3
International Journal of Epidemiology
74 papers in training set
Top 0.2%
7.1%
4
EClinicalMedicine
21 papers in training set
Top 0.1%
6.8%
5
The Lancet
16 papers in training set
Top 0.1%
4.3%
6
Public Health
34 papers in training set
Top 0.1%
3.6%
50% of probability mass above
7
Scientific Reports
3102 papers in training set
Top 48%
2.3%
8
Nature Communications
4913 papers in training set
Top 49%
1.9%
9
eClinicalMedicine
55 papers in training set
Top 0.5%
1.8%
10
European Journal of Public Health
20 papers in training set
Top 0.4%
1.8%
11
BMJ Public Health
18 papers in training set
Top 0.2%
1.7%
12
International Journal of Infectious Diseases
126 papers in training set
Top 2%
1.7%
13
BMC Medicine
163 papers in training set
Top 4%
1.5%
14
Journal of Public Health
23 papers in training set
Top 0.5%
1.5%
15
BMC Public Health
147 papers in training set
Top 4%
1.2%
16
Frontiers in Public Health
140 papers in training set
Top 7%
0.9%
17
Journal of Epidemiology and Community Health
32 papers in training set
Top 0.5%
0.9%
18
The Journal of Infectious Diseases
182 papers in training set
Top 4%
0.9%
19
International Journal of Public Health
17 papers in training set
Top 0.3%
0.9%
20
Vaccine
189 papers in training set
Top 2%
0.9%
21
BMC Infectious Diseases
118 papers in training set
Top 5%
0.8%
22
Annals of Epidemiology
19 papers in training set
Top 0.5%
0.8%
23
BMJ
49 papers in training set
Top 1%
0.8%
24
Trials
25 papers in training set
Top 2%
0.7%
25
The Lancet Global Health
24 papers in training set
Top 1%
0.7%
26
PLOS Medicine
98 papers in training set
Top 5%
0.7%
27
Open Forum Infectious Diseases
134 papers in training set
Top 3%
0.7%
28
Clinical Infectious Diseases
231 papers in training set
Top 5%
0.7%
29
International Journal of Environmental Research and Public Health
124 papers in training set
Top 7%
0.7%
30
Eurosurveillance
80 papers in training set
Top 2%
0.6%